Open Orphan Plc (LON:ORPH – Get Free Report) rose 5.3% on Thursday . The company traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.12). Approximately 652,639 shares were traded during trading, a decline of 58% from the average daily volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).
Open Orphan Stock Up 5.3 %
The company has a debt-to-equity ratio of 10.88, a quick ratio of 1.16 and a current ratio of 1.19. The firm’s 50-day moving average is GBX 10 and its two-hundred day moving average is GBX 10. The stock has a market cap of £67.09 million and a P/E ratio of -25.30.
About Open Orphan
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than Open Orphan
- Stock Sentiment Analysis: How it Works
- MarketBeat Week in Review – 4/22 – 4/26
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to Invest in Blue Chip Stocks
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.
